Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
98.12
+0.47 (0.49%)
Aug 14, 2025, 1:33 PM EDT
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$648,117
Profits / Employee
$129,317
Market Cap
118.83B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
Sanofi News
- 7 days ago - Sanofi: Playing To Win - Seeking Alpha
- 7 days ago - Emcure Pharmaceuticals Reports Strong Q1 FY26 Results with 16% Revenue Growth and 41% Jump in Profit - Business Upturn
- 7 days ago - Novavax raises 2025 revenue target to $1.05B with milestone payments and streamlined expenses as Sanofi partnership progresses - Seeking Alpha
- 8 days ago - Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewsWire
- 10 days ago - What's Driving the Market Sentiment Around Sanofi? - Benzinga
- 13 days ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 13 days ago - Arrowhead unit sells rights for plozasiran to Sanofi in Greater China - Seeking Alpha
- 13 days ago - European drugmakers fall after Trump raises stakes over US drug price cuts - Reuters